High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Asıl Yazarlar: | Yue, W, Oppermann, U |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2011
|
Benzer Materyaller
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
Yazar:: Yue, W, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
Yazar:: Yue, W, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Structural genomics and high throughput structural biology /
Yazar:: Sundstrom, Michael, ve diğerleri
Baskı/Yayın Bilgisi: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
Yazar:: Oppermann, U, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
Yazar:: Oppermann, U, ve diğerleri
Baskı/Yayın Bilgisi: (2000)